tirzepatide new era (Mounjaro): A Dual-Action Breakthrough for Type 2 Diabetes and Weight Loss Compounding Pharmacy - New Era
Description
Full reimbursement is likely to be unaffordable for most publicly funded healthcare systems in the short term, but a steady reduction in the threshold for reimbursement is believed to be inevitable in the medium to long term
Breastfeeding: It is not known whether tirzepatide is excreted in human milk
Some compounded formulations include additional ingredients
HIGHLIGHTS OF PRESCRIBING INFORMATION
Rather than stopping cold turkey, most protocols involve stepping down from your current dose to a lower maintenance dose, then further tapering before full discontinuation
